Arch Iran Med. 2021;24: 903-909.
doi: 10.34172/aim.2021.135
  Abstract View: 508
  PDF Download: 299

Original Article

Systemic Treatments in Pediatric Psoriasis: A Retrospective Single-Center Study

Gokhan Sahin 1* ORCID logo, Fatma Aydin 1 ORCID logo, Esra Pancar Yuksel 1

1 Department of Dermatology, Medical Faculty, Ondokuz Mayıs University, Samsun, Turkey
*Corresponding Author: *Corresponding Author: Gökhan Şahin, MD; Department of Dermatology, Medical Faculty, Ondokuz Mayıs University, 55139, Kurupelit, Samsun, Turkey. Tel:+90-362 312 1919; Fax:+90-362 457 60 29; Email: , Email: sgokhan55@hotmail.com


Background: Systemic therapies commonly used in adult psoriasis are mostly used only off-label in children and little is known about the efficacy and tolerability of these drugs in this population. In this study, we aimed to evaluate the efficacy and safety of systemic treatments in pediatric patients with psoriasis.

Methods: Data were obtained retrospectively from the Department of Dermatology, Ondokuz Mayis University, School of Medicine between 2010–2019. Our study consisted of 742 pediatric patients (age ≤18 years) with psoriasis. Demographic data, adverse events of systemic treatments and healing periods were considered.

Results: A total of 195 patients received systemic treatment. The mean age of onset of disease and the initiation of systemic therapy were 9.68±4.62 and 11.33±4.38 years, respectively. Patients received methotrexate (n=52, 26.67%), cyclosporine (n=18, 9.24%), acitretin (n=106, 54.35%) and others (biologics and/or one of conventional treatments) (n=19, 9.74%) as systemic therapy. Adverse events occurred in 12 patients (incidence of 6.15%, and its related 95% confidence interval of 2.75%, 9.56%) and nine of them had to discontinue the medication due to those adverse events. Healing periods calculated in the remaining 186 patients were 13.25±5.87, 10.85±5.67, 11.05±7.00, and 9.41±4.16 (mean±SD) weeks for acitretin, methotrexate, cyclosporine, and others, respectively. No statistically significant differences were noted between the treatments regarding the healing periods.

Conclusion: All treatments were effective and none of them was superior in terms of the healing period. Systemic treatments used in adults can also be used in pediatric patients with psoriasis with similar efficacy and safety rates as long as routine monitoring is provided.

Keywords: Adverse events, Efficacy, Healing period, Pediatric psoriasis, Systemic treatments

Cite this article as: Sahin G, Aydin F, Yuksel EP. Systemic treatments in pediatric psoriasis: a retrospective single-center study. Arch Iran Med. 2021;24(12):903-909. doi: 10.34172/aim.2021.135
First Name
Last Name
Email Address
Security code

Abstract View: 509

Your browser does not support the canvas element.

PDF Download: 299

Your browser does not support the canvas element.

Submitted: 08 Sep 2020
Revision: 06 Feb 2021
Accepted: 20 Feb 2021
ePublished: 01 Dec 2021
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)